Actually it is beyond a Phase III asset as it made it all the way to approval (in France).
One thing I think investors should look into in detail is Phase III breast cancer trial paper [1]. I have attached it, because I don’t think a lot of people have had a chance to read it.
1. J. Natl. Cancer Inst. 1991 Cowan.pdf
General Comments / Chat, page-82
-
-
- There are more pages in this discussion • 11,147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.57 |
Change
-0.035(2.18%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.55 | $436.5K | 271.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2045 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2045 | 1.570 |
3 | 5375 | 1.560 |
1 | 1087 | 1.555 |
3 | 3669 | 1.550 |
2 | 2400 | 1.540 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 1000 | 1 |
1.585 | 3600 | 2 |
1.590 | 1361 | 1 |
1.620 | 2815 | 1 |
1.650 | 1000 | 1 |
Last trade - 14.47pm 30/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online